Once you hit this number, you wont owe for covered services for the remainder of the year, presuming you stay in-network
Sarri B, Martnez-Lpez S, Garca-Cordero J, Gonzlez-Rmila S, Mateos R, Bravo L
Interestingly, WD was highest in group with GLS 0 to -18%, lowest in the group with normal GLS and increased again in group with GLS 22% and above showing a unique bimodal distribution
As of July 1, 2025, many Aetna standard commercial plans removed Zepbound from their formularies when prescribed for the purpose of weight management
Gangopadhyay KK, Singh P
The initial Phase 1 PK clinical trial results are encouraging in establishing the drug's tolerability and dosing regimen, but further data from Phase 1b and subsequent trials will be necessary to determine its efficacy and full safety profile, particularly for the treatment of obesity and T2D